Therapeutic Intervention
After hospitalization of the patient in the stroke unit, antithrombotic and neuroprotective therapy was initiated: 30ml Cerebrolysin intravenously once daily for 16 days and oral administration of high-dose aspirin (326 mg) once daily for 9 days, followed by low dose Aspirin (75 mg). In addition, the patient received basic stroke therapy in accordance with the AHA-ASA recommendations and the clinical protocol of the Ministry of Health of the Republic of Belarus. For the concomitant hypertension, candesartan (8 mg once daily) and indapamide (2.5 mg once daily) were administered. Due to the fact that the patient has a very high risk of developing fatal cardiovascular diseases, atorvastatin (40 mg once daily) was prescribed to lower cholesterol levels. Furthermore, the patient received gastroprotection, with 20mg pantoprazole once daily during the entire course of treatment.